JB Chemicals & Pharmaceuticals Limited announced today, February 5, 2026, that its Board of Directors has approved an interim dividend of ₹12.70 per equity share for the financial year 2025-26. The dividend is set to be credited to shareholders on or after February 25, 2026. In addition to the dividend, the Board has also approved the appointment of Mr. Kaushal Solanki as the Chief Financial Officer (CFO) and Key Managerial Personnel of the Company, effective February 5, 2026. Mr. Solanki is a Chartered Accountant with over 30 years of experience in finance, including significant roles at Torrent Pharmaceuticals Limited, where he was involved in various aspects of financial reporting, audit, tax, and M&A.
